Phylogica Limited announced the appointment of Professor Shohei Koide to the Scientific Advisory Board. Together with the recent SAB appointments of Prof. Judy Lieberman and Dr. Stephen Doberstein, Professor Koide will serve as a strategic resource for Phylogica as the company continues to develop its intracellular drug delivery technology. Dr. Koide is Professor of Biologics Design in the Department of Biochemistry and Molecular Pharmacology at New York University School of Medicine, and Director of the Cancer Biologics platform at the Perlmutter Cancer Center at NYU Langone Health.